ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
 
Latest News and Events

Congratulations to Cancer Institute New South Wales Medical Research Award Recipients 08/08/2013
ANZMTG Members receive top honours in Medical Research: A huge congratulations to 3 ANZMTG investigators who received some of NSW's highest recognition in medical research at the recent Cancer Institute New South Wales event. more...
Yervoy (Ipilimumab) subsidised by the Pharmaceutical Benefits Scheme - Media Release 01/08/2013
There is much to celebrated by the Australian melanoma community since the approval of the drug Yervoy (Ipilimumab) to be subsidised by the under the Pharmaceutical Benefits Scheme (PBS) in Australia. more...
Ipilimumab has now been approved for PBS reimbursement in Australia 01/07/2013
Over the weekend the Australian government has confirmed that Ipilimumab will now be listed for subsidy under the Pharmaceutical Benefits Scheme (PBS) in Australia. This will mean that the cost of the drug is significantly reduced for patients which is a great outcome. more...
Australia & Asia Clinical Oncology Research Development Workshop 2014. 21/06/2013
Applications open soon for the Australia & Asia Pacific Clinical Oncology Research Development Workshop (ACORD) 2014. more...
Cancer Council NSW Workshop for Young Adult Cancer Survivors 20/06/2013
Cancer Council NSW is holding a day event for cancer survivors aged 18-45. more...
Extension of Abstract Submission Deadline for the Global Skin Cancer Conference 17/06/2013
Registration is now open and special Group and Early discounts are availableuntil 23 August 2013. Register online now. more...